ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 159 shares, the number of shares held decreased 0.35% compared to the previous period and now represents 1.22% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 35,042 shares, the number of shares held increased 17.03% compared to the previous period and now represents 1.88% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 7,989 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 8.19% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 1,440 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 2.62% of the total position.
      91Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 17,868 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.49% of the total position.
      52Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 7,701 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 3.1% of the total position.
      4.59KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 7,917 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 4.84% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 54,156 shares, the number of shares held decreased 8.11% compared to the previous period and now represents 5.55% of the total position.
      22Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 846 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 4.29% of the total position.
      33Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-05 07:13
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 6,291 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 8.06% of the total position.
      114Comment
      Report
       
       
       
       

      Most Discussed